Hopewell Therapeutics Inc. is creating pipelines of lipid nanoparticle (LNP)-based therapeutics. Our mission is to deliver on the promise of the novel drug delivery technology and mRNA
sciences to bring new medicines to patients. We are a rapidly growing team with VC backed funding, and proprietary
technology that has huge potential to disrupt current area of organ targeted
delivery, vaccines, and nucleic acid-based therapy.